Judy Johnson - Concepedia

Author

Judy Johnson

Research Triangle Park Foundation

Also Known As

J. E. Johnson, Johnson, Judy, Judy Johnson

Publications

783

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)Aaron Diamond AIDS Research Center University of North Carolina at Chapel Hill University of Colorado Health

About

Judy Johnson is an author at Research Triangle Park Foundation specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	129
2	Immunology	3	3	99
3	Pharmacology	3	3	93
4	Social Sciences	1	1	17
5	Pathology	1	1	19

Judy Johnson

Publications

712

Citations

H-Index

Page 1

	Year	Citations
Early Virologic Nonresponse to Tenofovir, Abacavir, and Lamivudine in HIV‐Infected Antiretroviral‐Naive Subjects Joel E. Gallant, Allan Rodríguez, Winkler G. Weinberg, The Journal of Infectious Diseases	2005	146
Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin Martin O’Donnell, Clive Kearon, Judy Johnson, Annals of Internal Medicine	2007	108
HIV-1 RNA levels and the development of clinical disease A. Philips, Joseph J. Eron, John Bartlett, AIDS	1996	90
Long-Term Results of Initial Therapy With Abacavir and Lamivudine Combined With Efavirenz, Amprenavir/Ritonavir, or Stavudine John Bartlett, Judy Johnson, Gisela Herrera, JAIDS Journal of Acquired Immune Deficiency Syndromes	2006	73
Virologic and Immunologic Effect of Antiretroviral Therapy on HIV-1 in Gut-Associated Lymphoid Tissue Andrew H. Talal, Simon Monard, Mika Vesanen, JAIDS Journal of Acquired Immune Deficiency Syndromes	2001	47
Persistent Antiretroviral Activity of Nucleoside Analogues After Prolonged Zidovudine and Lamivudine Therapy as Demonstrated by Rapid Loss of Activity After Discontinuation Joseph J. Eron, John Bartlett, Jorge Santana, JAIDS Journal of Acquired Immune Deficiency Syndromes ImmunologyPharmacotherapyAntiviral DrugResistant Hiv-1Rapid Loss	2004	40
Emergence of Dual Resistance to Zidovudine and Lamivudine in HIV-1–Infected Patients Treated With Zidovudine Plus Lamivudine as Initial Therapy Daniel R. Kuritzkes, David Shugarts, Minoo Bakhtiari, JAIDS Journal of Acquired Immune Deficiency Syndromes Human RetrovirusPharmacologyImmunologyAntiviral Drug DevelopmentVirology	2000	40
Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals Andrew Phillips, Joseph J. Eron, John Bartlett, AIDS	1997	29
Abacavir Expanded Access Program for Adult Patients Infected with Human Immunodeficiency Virus Type 1 Harold A. Kessler, Judy Johnson, Stephen Follansbee, Clinical Infectious Diseases	2002	24
Treatment of Chronic Hepatitis C with Amantadine John S. Goff, R. Matthew Reveille, Judy Johnson Digestive Diseases and Sciences	2000	21

Page 1